Novartis AG NVS
Regular-session close
After hours · Nov 20, 7:17 PM ET
- YTD
- +9.14%
- 1 year
- +21.00%
Held by funds
59 US ETFs and mutual funds hold NVS · largest positions
- VPMCX 0.66% of fund $606.33M
- VHCOX 0.56% of fund $172.68M
- DFIV 0.63% of fund $137.96M
- DFAI 0.70% of fund $123.77M
- DFIC 0.76% of fund $112.79M
- VPCCX 0.57% of fund $95.49M
- AVDE 0.49% of fund $93.79M
- DIHP 1.43% of fund $91.26M
- DFAX 0.69% of fund $80.41M
- FENI 0.42% of fund $48.81M
- AFTY 3.20% of fund $40.47M
- PPH 3.64% of fund $38.18M
- BFLX 1.34% of fund $35.11M
- FVL 0.41% of fund $33.46M
- IDVO 1.64% of fund $20.83M
- LCAP 1.04% of fund $18.99M
- FTHI 0.71% of fund $17.73M
- PID 1.86% of fund $16.01M
- GMOI 1.90% of fund $12.96M
- FMSDX 0.33% of fund $12.39M
Ownership
- Institutions 7.23%
- Insiders 0.01%
- Public and other holders 92.8%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fisher Asset Management, LLC | 0.82% | 16,762,528 | 2.52B | Sep 29, 2026 |
| Morgan Stanley | 0.41% | 8,437,223 | 1.27B | Sep 29, 2026 |
| Dimensional Fund Advisors LP | 0.39% | 7,875,541 | 1.18B | Sep 29, 2026 |
| Primecap Management Company | 0.32% | 6,585,464 | 990.78M | Sep 29, 2026 |
| LOOMIS SAYLES & CO L P | 0.24% | 4,834,120 | 727.29M | Sep 29, 2026 |
| Bank of America Corporation | 0.22% | 4,560,856 | 686.18M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | 0.21% | 4,252,875 | 639.85M | Jun 29, 2026 |
| DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT. | 0.10% | 2,060,639 | 310.02M | Jul 30, 2026 |
| LOOMIS SAYLES FUNDS II-Loomis Sayles Growth Fund | 0.07% | 1,417,894 | 213.32M | Jun 29, 2026 |
| VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund | 0.06% | 1,211,220 | 182.23M | Jun 29, 2026 |
| Franklin Mutual Series Funds-FRANKLIN MUTUAL GLOBAL DISCOVERY FUND | 0.06% | 1,192,174 | 179.36M | Jun 29, 2026 |
| Principal Funds, Inc-Equity Income Fund | 0.05% | 935,325 | 140.72M | Jul 30, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs NVS, and what each was last paid
Vasant Narasimhan, Chief Executive OfficerAverage age 55
| Name | Title | Pay | Age |
|---|---|---|---|
| Vasant Narasimhan | Chief Executive Officer | $9.19M | 50 |
| Victor Bulto | President of US | $4.06M | 48 |
| Mukul Mehta | Chief Financial Officer | $3.77M | 53 |
| Patrick Horber | President of International | $3.32M | 56 |
| Karen L. Hale | Chief Legal & Compliance Officer | $2.60M | 58 |
| Steffen Lang | President of Operations | $2.59M | 59 |
| Robert Kowalski | Chief People & Organization Officer | $2.33M | 58 |
| Paul Penepent | Head of Group Financial Reporting and Accounting | — | — |
| Sloan Simpson | Global Head of Investor Relations | — | — |
| Evan Beckman | Global Head of Translational Medicine at Novartis Institute for BioMedical Research | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
No insider holdings on record
